DOCSLIB.ORG

Molecular Characterization of Neurotransmitter Transporters

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Molecular Characterization of Neurotransmitter Transporters Molecular Characterization of Neurotransmitter Transporters Saad Shafqat, Maria Velaz-Faircloth, Ana Guadaiio-Ferraz, and Robert T. Fremeau, Jr. Downloaded from https://academic.oup.com/mend/article/7/12/1517/2714704 by guest on 06 October 2020 Departments of Pharmacology and Neurobiology Duke University Medical Center Durham, North Carolina 27710 INTRODUCTION ogical processes. For example, blockade and/or rever- sal of the high affinity plasma membrane L-glutamate transporter during ischemia or anoxia elevates the ex- Rapid chemical signaling between neurons and target tracellular concentration of L-glutamate to neurotoxic cells is dependent upon the precise control of the levels resulting in nerve cell damage (7). Conversely, concentration and duration of neurotransmitters in syn- specific GABA uptake inhibitors are being developed as aptic spaces. After transmitter release from activated potential anticonvulsant and antianxiety agents (8). The nerve terminals, the principal mechanism involved in the ability of synaptic transporters to accumulate certain rapid clearance from the synapse of the biogenic amine neurotransmitter-like toxins, including N-methyW and amino acid neurotransmitters is active transport of phenylpyridine (MPP+), 6-hydroxydopamine, and 5,6- the transmitter back into presynaptic nerve terminals or dihydroxytryptamine, suggests a role for these active glial surrounding cells by one of a large number of transport proteins in the selective vulnerability of neu- specific, pharmacologically distinguishable membrane rons to exogenous agents (9). Therefore, a detailed transport proteins (1). High affinity, Na+-dependent up- understanding of the molecular structure, function, and take activities, analogous to the noradrenergic carrier regulation of neurotransmitter transporters will: 1) en- first described at peripheral synapses by Axelrod and hance our understanding of synaptic signaling, 2) elu- colleagues (2) have been identified in mammalian cen- cidate the potential role of transporter defects in neu- tral nervous system (CNS) nerve terminals for the bio- rologic and psychiatric disorders; and 3) aid in the genie amine neurotransmitters including norepinephrine development of novel therapeutic agents. Finally, the (NE), dopamine (DA), and serotonin (5HT) for the ex- discovery of novel synaptic transporters may contribute citatory amino acid neurotransmitters L-glutamate and to the identification of new synaptic regulatory sub- L-aspartate, and for the inhibitory amino acid neuro- stances. transmitters r-amino butyric acid (GABA) and glycine (3). The primary function of plasma membrane neuro- transmitter transporters is to clear the synapse of the TWO DISTINCT GENE FAMILIES ENCODE neurotransmitter between nerve impulses and to re- PLASMA MEMBRANE NEUROTRANSMllTER plenish neurotransmitter levels in presynaptic nerve TRANSPORTERS terminals. In certain cases, Na+-dependent transport processes may also mediate the presynaptic accumu- lation of neurotransmitter precursors as well. For ex- Neurotransmitter transporters are representative mem- ample, the rate-limiting step in the biosynthesis of ace- bers of a family of proteins that transduce free energy tylcholine appears to be Na+dependent choline uptake stored in an electrochemical gradient into work in the into cholinergic nerve terminals by a hemicholinium- form of a concentration gradient. Active transport of sensitive high affinity choline transporter (5). neurotransmitters across the plasma membrane is Neurotransmitter transporters represent critical tar- driven by the transmembrane Na+ gradient generated gets for therapeutic and pathological alterations of syn- by the plasma membrane Na+/K+ ATPase (reviewed in aptic function. This is particularly apparent with the ref. 4). Additional ions are also required for transport of tricyclic antidepressants, amphetamines, and cocaine, many neurotransmitters, including extracellular Cl- and agents that block biogenic amine transport and produce intracellular K’. These ion sensitivities reflect cotrans- dramatic behavioral changes (6). Abnormalities of neu- port of the ions with the neurotransmitter during each rotransmitter transport can contribute to neuropathol- translocation cycle. In recent years, molecular cloning studies have re- 0933-9909/93/1517-15!23903.00/0 vealed that two distinct gene families code for plasma Molecular Endocrin&qy Copyright 0 1993 by The Endocrine society membrane neurotransmitter transporter proteins. 1517 MOL ENDO.1993 Vol7No.12 1518 These include: 1) the Na+- (and Cl-)-dependent family and colleagues (10) on the purification and cloning of a that includes transporters for GABA, NE, DA, 5HT, high affinity Na+- (and Cl-)-dependent GABA trans- glycine, proline, taurine, betaine, and creatine; and 2) porter from rat brain (rGAT-1). Subsequently, Amara the Na+- (and K+)-dependent, but Cl--independent, fam- and colleagues (11) isolated a cDNA clone for a cocaine- ily of transporters that include transporters for the and antidepressant-sensitive human NE transporter excitatory amino acids L-glutamate and L-aspartate (hNET) by expression cloning (11). Despite dramatic (Fig. 1). These two families of plasma membrane trans- differences in pharmacological sensitivities to sub- porters exhibit significant differences in their ionic re- strates and antagonists, rGAT-1 and hNET possessed quirements and proposed structures which are likely to significant (46%) but dispersed amino acid sequence reflect underlying differences in transport mechanisms. identities and exhibited similar inferred membrane to- This review will discuss recent advances in our under- pographies. No significant amino acid sequence identity Downloaded from https://academic.oup.com/mend/article/7/12/1517/2714704 by guest on 06 October 2020 standing of the structure, expression, and extent of the was observed, however, between these two neuro- molecular diversity of these two neurotransmitter trans- transmitter transporters and other membrane transport porter gene families. proteins whose sequences had been determined, in- cluding the mammalian facilitated glucose transporters Na+- (and Cl-)-Dependent Neurotransmitter (12) the mammalian Na+/glucose cotransporter (13) Transporters the prokaryotic Na+dependent cotranspotters (14) or the ATP-binding cassette membrane transporters, in- The molecular characterization of neurotransmitter cluding the multidrug resistance P-glycoproteins (15) transporters began with the pioneering work of Kanner and the cystic fibrosis transmembrane conductance regulator (16). These results established the presence of a distinct gene family of neurotransmitter transport Na+- (and Cl-1 -Dependent Transporters proteins and paved the way for the rapid identification of additional members of this novel gene family. Polymerase chain reaction (PCR) and low stringency screening techniques have been used to isolate addi- tional members of the emerging family of Na+- (and Cl-)-dependent neurotransmitter transporters. Based upon amino acid sequence conservation (Fig. 2) these cDNAs can be divided into three subfamilies including: NH, 1 1) the GABA, betaine, taurine, and creatine transport- COOH 1 ers; 2) the biogenic amine (NE, DA, and 5HT) trans- Na+- (and K+) -Dependent Glutamate Transporters porters; and 3) the amino acid (L-proline and glycine) transporters. The observation that transporters for sub- Pl strates with no known neurotransmitter role, such as betaine and creatine, belong to this family of transport- ers indicates that this family may subserve a greater diversity of physiological functions, and should more correctly be referred to as the Na+- (and Cl-)-dependent plasma membrane transporter family. -2 COOH 2 As depicted in Fig. 1, a tentative structural model for “Orphan” clonea the Na+- (and Cl-)-dependent plasma membrane trans- Y porters predicts approximately 12 transmembrane (Y- helical domains, cytoplasmic NHP- and COOH-termini, and a large, glycosylated, extracellular loop separating putative transmembrane domains 3 and 4. This pro- posed topographical model remains to be experimen- tally verified. Although in each case a single cDNA is able to induce high affinity Na+- (and Cl-)-dependent NH, - transport in a nonneural cell line, the subunit stoichi- COOH - ometry of the native transporter complex has not been Fig. 1. Schematicmodels depicting the proposed transmem- determined for any member of this family of membrane brane topology of the two major familiesof plasma membrane transport proteins. neurotransmittertransporters. Potential N-linkedglycosylation sites on the presumed extracellulardomains are depicted. Due The Subfamily of GABA, Betaine, Taurine, and to the subjective nature of hydropathy analysis, the model Creatine Transporters proposed for the glutamate transporters is controversial(see text). Orphan clones refer to recentlydescribed putative trans- porters (56, 57) which bear sequence homology to the Na+- An exciting result to emerge from the molecular char- (and Cl-)-dependenttransporters but exhibit a distinct inferred acterization of neurotransmitter transporters was the membrane topology. discovery that multiple transporter subtypes exist for Minireview 1519 certain neurotransmitters. Thus four distinct GABA activity (20). Because the subfamily of biogenic amine transporter cDNAs have been described which exhibit transporters share this conserved arginine residue (see 50-69% amino acid sequence identity but differ in their Fig. 3), but the cognate biogenic amine substrates
Load more

Recommended publications
  • Inhibitory Role for GABA in Autoimmune Inflammation
    Inhibitory role for GABA in autoimmune inflammation Roopa Bhata,1, Robert Axtella, Ananya Mitrab, Melissa Mirandaa, Christopher Locka, Richard W. Tsienb, and Lawrence Steinmana aDepartment of Neurology and Neurological Sciences and bDepartment of Molecular and Cellular Physiology, Beckman Center for Molecular Medicine, Stanford University, Stanford, CA 94305 Contributed by Richard W. Tsien, December 31, 2009 (sent for review November 30, 2009) GABA, the principal inhibitory neurotransmitter in the adult brain, serum (13). Because actions of exogenous GABA on inflammation has a parallel inhibitory role in the immune system. We demon- and of endogenous GABA on phasic synaptic inhibition both strate that immune cells synthesize GABA and have the machinery occur at millimolar concentrations (5, 8, 9), we hypothesized that for GABA catabolism. Antigen-presenting cells (APCs) express local mechanisms may also operate in the peripheral immune functional GABA receptors and respond electrophysiologically to system to enhance GABA levels near the inflammatory focus. We GABA. Thus, the immune system harbors all of the necessary first asked whether immune cells have synthetic machinery to constituents for GABA signaling, and GABA itself may function as produce GABA by Western blotting for GAD, the principal syn- a paracrine or autocrine factor. These observations led us to ask thetic enzyme. We found significant amounts of a 65-kDa subtype fl further whether manipulation of the GABA pathway in uences an of GAD (GAD-65) in dendritic cells (DCs) and lower levels in animal model of multiple sclerosis, experimental autoimmune macrophages (Fig. 1A). GAD-65 increased when these cells were encephalomyelitis (EAE). Increasing GABAergic activity amelio- stimulated (Fig.
    [Show full text]
  • The Concise Guide to Pharmacology 2019/20
    Edinburgh Research Explorer THE CONCISE GUIDE TO PHARMACOLOGY 2019/20 Citation for published version: Cgtp Collaborators 2019, 'THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters', British Journal of Pharmacology, vol. 176 Suppl 1, pp. S397-S493. https://doi.org/10.1111/bph.14753 Digital Object Identifier (DOI): 10.1111/bph.14753 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: British Journal of Pharmacology General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 28. Sep. 2021 S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Transporters. British Journal of Pharmacology (2019) 176, S397–S493 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters Stephen PH Alexander1 , Eamonn Kelly2, Alistair Mathie3 ,JohnAPeters4 , Emma L Veale3 , Jane F Armstrong5 , Elena Faccenda5 ,SimonDHarding5 ,AdamJPawson5 , Joanna L
    [Show full text]
  • Interplay Between Metformin and Serotonin Transport in the Gastrointestinal Tract: a Novel Mechanism for the Intestinal Absorption and Adverse Effects of Metformin
    INTERPLAY BETWEEN METFORMIN AND SEROTONIN TRANSPORT IN THE GASTROINTESTINAL TRACT: A NOVEL MECHANISM FOR THE INTESTINAL ABSORPTION AND ADVERSE EFFECTS OF METFORMIN Tianxiang Han A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Eshelman School of Pharmacy. Chapel Hill 2013 Approved By: Dhiren R. Thakker, Ph.D. Michael Jay, Ph.D. Kim L. R. Brouwer, Pharm.D., Ph.D. Joseph W. Polli, Ph.D. Xiao Xiao, Ph.D. © 2013 Tianxiang Han ALL RIGHTS RESERVED ii ABSTRACT TIANXIANG HAN: Interplay between Metformin and Serotonin Transport in the Gastrointestinal Tract: A Novel Mechanism for the Intestinal Absorption and Adverse Effects of Metformin (Under the direction of Dhiren R. Thakker, Ph.D.) Metformin is a widely prescribed drug for Type II diabetes mellitus. Previous studies have shown that this highly hydrophilic and charged compound traverses predominantly paracellularly across the Caco-2 cell monolayer, a well-established model for human intestinal epithelium. However, oral bioavailability of metformin is significantly higher than that of the paracellular probe, mannitol (~60% vs ~16%). Based on these observations, the Thakker laboratory proposed a “sponge” hypothesis (Proctor et al., 2008) which states that the functional synergy between apical (AP) transporters and paracellular transport enhances the intestinal absorption of metformin. This dissertation work aims to identify AP uptake transporters of metformin, determine their polarized localization, and elucidate their roles in the intestinal absorption and adverse effects of metformin. Chemical inhibition and transporter-knockdown studies revealed that four transporters, namely, organic cation transporter 1 (OCT1), plasma membrane monoamine transporter (PMAT), serotonin reuptake transporter (SERT) and choline high-affinity transporter (CHT) contribute to AP uptake of metformin in Caco-2 cells.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Tyrosine 140 of the γ-Aminobutyric Acid Transporter GAT-1 Plays A
    University of Montana ScholarWorks at University of Montana Biomedical and Pharmaceutical Sciences Faculty Biomedical and Pharmaceutical Sciences Publications 1997 Tyrosine 140 of the γ-Aminobutyric Acid Transporter GAT-1 Plays a Critical Role in Neurotransmitter Recognition Yona Bismuth Michael Kavanaugh University of Montana - Missoula Baruch I. Kanner Let us know how access to this document benefits ouy . Follow this and additional works at: https://scholarworks.umt.edu/biopharm_pubs Part of the Medical Sciences Commons, and the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Bismuth, Yona; Kavanaugh, Michael; and Kanner, Baruch I., "Tyrosine 140 of the γ-Aminobutyric Acid Transporter GAT-1 Plays a Critical Role in Neurotransmitter Recognition" (1997). Biomedical and Pharmaceutical Sciences Faculty Publications. 58. https://scholarworks.umt.edu/biopharm_pubs/58 This Article is brought to you for free and open access by the Biomedical and Pharmaceutical Sciences at ScholarWorks at University of Montana. It has been accepted for inclusion in Biomedical and Pharmaceutical Sciences Faculty Publications by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 272, No. 26, Issue of June 27, pp. 16096–16102, 1997 © 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Tyrosine 140 of the g-Aminobutyric Acid Transporter GAT-1 Plays a Critical Role in Neurotransmitter Recognition* (Received for publication, February 6, 1997, and in revised form, April 8, 1997) Yona Bismuth‡, Michael P. Kavanaugh§, and Baruch I. Kanner‡¶ From the ‡Department of Biochemistry, Hadassah Medical School, the Hebrew University, Jerusalem 91120, Israel and the §Vollum Institute, Oregon Health Science University, Portland, Oregon 97201 The g-aminobutyric acid (GABA) transporter GAT-1 is tify amino acid residues of GAT-1 involved in substrate bind- located in nerve terminals and catalyzes the electro- ing.
    [Show full text]
  • A Review of Glutamate Receptors I: Current Understanding of Their Biology
    J Toxicol Pathol 2008; 21: 25–51 Review A Review of Glutamate Receptors I: Current Understanding of Their Biology Colin G. Rousseaux1 1Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada Abstract: Seventy years ago it was discovered that glutamate is abundant in the brain and that it plays a central role in brain metabolism. However, it took the scientific community a long time to realize that glutamate also acts as a neurotransmitter. Glutamate is an amino acid and brain tissue contains as much as 5 – 15 mM glutamate per kg depending on the region, which is more than of any other amino acid. The main motivation for the ongoing research on glutamate is due to the role of glutamate in the signal transduction in the nervous systems of apparently all complex living organisms, including man. Glutamate is considered to be the major mediator of excitatory signals in the mammalian central nervous system and is involved in most aspects of normal brain function including cognition, memory and learning. In this review, the basic biology of the excitatory amino acids glutamate, glutamate receptors, GABA, and glycine will first be explored. In the second part of this review, the known pathophysiology and pathology will be described. (J Toxicol Pathol 2008; 21: 25–51) Key words: glutamate, glycine, GABA, glutamate receptors, ionotropic, metabotropic, NMDA, AMPA, review Introduction and Overview glycine), peptides (vasopressin, somatostatin, neurotensin, etc.), and monoamines (norepinephrine, dopamine and In the first decades of the 20th century, research into the serotonin) plus acetylcholine. chemical mediation of the “autonomous” (autonomic) Glutamatergic synaptic transmission in the mammalian nervous system (ANS) was an area that received much central nervous system (CNS) was slowly established over a research activity.
    [Show full text]
  • Prokaryotic Solute/Sodium Symporters: Versatile Functions and Mechanisms of a Transporter Family †
    Review Prokaryotic Solute/Sodium Symporters: Versatile Functions and Mechanisms of a Transporter Family † Tania Henriquez, Larissa Wirtz, Dan Su and Heinrich Jung * Microbiology, Department Biology 1, Ludwig Maximilians University Munich, D-82152 Martinsried, Germany; [email protected] (T.H.); [email protected] (L.W.); [email protected] (D.S.) * Correspondence: [email protected]; Tel.: +49-89-218074630 † This article is dedicated to the memory of Ron Kaback, an exceptional scientist and great mentor. Abstract: The solute/sodium symporter family (SSS family; TC 2.A.21; SLC5) consists of integral membrane proteins that use an existing sodium gradient to drive the uphill transport of various solutes, such as sugars, amino acids, vitamins, or ions across the membrane. This large family has representatives in all three kingdoms of life. The human sodium/iodide symporter (NIS) and the sodium/glucose transporter (SGLT1) are involved in diseases such as iodide transport defect or glu- cose-galactose malabsorption. Moreover, the bacterial sodium/proline symporter PutP and the so- dium/sialic acid symporter SiaT play important roles in bacteria–host interactions. This review fo- cuses on the physiological significance and structural and functional features of prokaryotic mem- bers of the SSS family. Special emphasis will be given to the roles and properties of proteins con- taining an SSS family domain fused to domains typically found in bacterial sensor kinases. Citation: Henriquez, T.; Wirtz, L.; Keywords: secondary transport; solute/sodium symport; SLC5; PutP; signal transduction; bacterial Su, D.; Jung, H. Prokaryotic two-component systems; bacterial sensor kinase Solute/Sodium Symporters: Versatile Functions and Mechanisms of a Transporter Family.
    [Show full text]
  • GAT-1, a High-Affinity GABA Plasma Membrane Transporter, Localized to Neurons and Astroglia in the Cerebral Cortex
    The Journal of Neuroscience, November 1995, 75(11): 7734-7746 GAT-1, a High-Affinity GABA Plasma Membrane Transporter, Localized to Neurons and Astroglia in the Cerebral Cortex Andrea Minelli,’ Nicholas C. Brecha, 2,3,4,5,6Christine Karschiq7 Silvia DeBiasi,8 and Fiorenzo Conti’ ‘Institute of Human Physiology, University of Ancona, Ancona, Italy, *Department of Neurobiology, 3Department of Medicine, 4Brain Research Institute, and 5CURE:VA/UCLA Gastroenteric Biology Center, UCLA School of Medicine, and 6Veterans Administration Medical Center, Los Angeles, CA, 7Max-Planck-lnstitute for Experimental Medicine, Gottingen, Germany, and 8Department of General Physiology and Biochemistry, Section of Histology and Human Anatomy, University of Milan, Milan, Italy High affinity, GABA plasma membrane transporters influ- into GABAergic axon terminals, GAT-1 influences both ex- ence the action of GABA, the main inhibitory neurotrans- citatory and inhibitory transmission by modulating the mitter. The cellular expression of GAT-1, a prominent “paracrine” spread of GABA (Isaacson et al., 1993), and GABA transporter, has been investigated in the cerebral suggest that astrocytes may play an important role in this cortex of adult rats using in situ hybridizaton with %-la- process. beled RNA probes and immunocytochemistry with affinity [Key words: GABA, GABA transporlers, neocottex, syn- purified polyclonal antibodies directed to the C-terminus of apses, neurons, astrocytes] rat GAT-1. GAT-1 mRNA was observed in numerous neurons and in Synaptic transmissionmediated by GABA plays a key role in some glial cells. Double-labeling experiments were per- controlling neuronal activity and information processingin the formed to compare the pattern of GAT-1 mRNA containing mammaliancerebral cortex (Krnjevic, 1984; Sillito, 1984; Mc- and GAD67 immunoreactive cells.
    [Show full text]
  • Sorting of the Vesicular GABA Transporter to Functional Vesicle Pools by an Atypical Dileucine-Like Motif
    10634 • The Journal of Neuroscience, June 26, 2013 • 33(26):10634–10646 Cellular/Molecular Sorting of the Vesicular GABA Transporter to Functional Vesicle Pools by an Atypical Dileucine-like Motif Magda S. Santos,1 C. Kevin Park,1 Sarah M. Foss,1,2 Haiyan Li,1 and Susan M. Voglmaier1 1Department of Psychiatry, and 2Graduate Program in Cell Biology, University of California, San Francisco, School of Medicine, San Francisco, California 94143-0984 Increasing evidence indicates that individual synaptic vesicle proteins may use different signals, endocytic adaptors, and trafficking pathways for sorting to distinct pools of synaptic vesicles. Here, we report the identification of a unique amino acid motif in the vesicular GABA transporter (VGAT) that controls its synaptic localization and activity-dependent recycling. Mutational analysis of this atypical dileucine-like motif in rat VGAT indicates that the transporter recycles by interacting with the clathrin adaptor protein AP-2. However, mutation of a single acidic residue upstream of the dileucine-like motif leads to a shift to an AP-3-dependent trafficking pathway that preferentially targets the transporter to the readily releasable and recycling pool of vesicles. Real-time imaging with a VGAT-pHluorin fusion provides a useful approach to explore how unique sorting sequences target individual proteins to synaptic vesicles with distinct functional properties. Introduction ery to different vesicle pools, or molecular heterogeneity of SVs How proteins are sorted to synaptic vesicles (SVs) has been a that could determine their functional characteristics (Mor- long-standing question in cell biology. At the nerve terminal, genthaler et al., 2003; Salazar et al., 2004; Voglmaier and Ed- synaptic vesicles undergo exocytosis and then reform through wards, 2007; Hua et al., 2011a; Lavoie et al., 2011; Raingo et al., endocytic events.
    [Show full text]
  • Gene Forward Primer Reverse Primer
    Supplementary Table S1. qPCR primer sequences. Gene Forward Primer Reverse Primer SLC44A1 TTTCCTGCTATGCCAAGTTTGC CCAGAATGGTTAAGATCCACACA SLC44A2 AAAGGGAGGGAGAGTTTTGC CCCTTGGGTGGGTTTAGTTT SLC44A3 GTCCAAAAGCAGACTCACTGT GCAAATAGGGAGTAGCACTCAGG SLC44A4 GGGATCAGCGGTCTTATTGA GCGCAGAAGCAAGATAAAC SLC44A5 ACCCCAGAAGAGCAGCCTAT TTTAGCAACACGGAGGGACT SLC22A1 TAATGGACCACATCGCTCAA ACCCCTGATAGAGCACAGA SLC22A2 AAGAATGGGGAATCACAATGG AGATGTGGACGCCAAGATTC SLC5A7 TTGGTGGCCGAGATATTGGTT GCCATTGATATACCCTCCTCCG PCYT1A CTCTGATGCAAGCGAAGAACC ATCACCGTGAAGCCTTTGAAG CHKΑ CTTGGTGATGAGCCTCGGAA AAGTGACCTCTCTGCGAGAA CHKB AGTCTCGGTTCCAGTTCTAC CTTCTGCTCGTTGTTCCTCC β ACTIN CCAACCGCGAGAAGATGACC GGAGTCCATCACGATGCCAG HSP90 CCAGTTTGGTGTCGGTTTCTAT CTGGGTATCGTTGTTGTGTTTTG JFH1 Hepatitis C Virus GTCTGCGGAACCGGTGAGTA GCCCAAATGGCCGGGATA Viruses 2020, 12, x; doi: FOR PEER REVIEW www.mdpi.com/journal/viruses Viruses 2020, 12, x FOR PEER REVIEW 2 of 3 Supplementary Figure S1. FBS-cultured Huh7.5 choline transporter transcript expression Supplementary Figure S1. FBS-cultured Huh7.5 choline transporter transcript expression. RNA was isolated from FBS-cultured Huh7.5 cells to measure choline transporter (SLC44A1-5; choline transporter-like 1-5, and SLC22A1 and 2; organic cation transporter 1 and 2) transcript expression. All groups are shown relative to the expression of SLC44A1 and normalized to the average of β ACTIN and HSP90. Supplementary Figure S2. HS-cultured Huh7.5 choline uptake kinetics Supplementary Figure S2. HS-cultured Huh7.5 choline uptake kinetics. Choline uptake saturation kinetics from HS-cultured Huh7.5 cells, fit to a Michaelis-Menten curve. Data are mean±SEM and are representative of 3 independent experiments. Viruses 2020, 12, x FOR PEER REVIEW 3 of 3 Supplementary Figure S3. Inhibition of choline transport in FBS-cultured infected cells Supplementary Figure S3. Inhibition of choline transport in FBS-cultured infected cells. FBS-cultured Huh7.5 cells were infected at an MOI of 1 for 24 h in the presence or absence of 20 or 200 μM hemicholinium-3 (HC-3) to inhibit choline uptake.
    [Show full text]
  • Therapeutic Effects of Jiaotai Pill on Rat Insomnia Via Regulation of GABA Signal Pathway
    Tang et al Tropical Journal of Pharmaceutical Research September 2017; 16 (9): 2135-2140 ISSN: 1596-5996 (print); 1596-9827 (electronic) © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved. Available online at http://www.tjpr.org http://dx.doi.org/10.4314/tjpr.v16i9.13 Original Research Article Therapeutic effects of Jiaotai pill on rat insomnia via regulation of GABA signal pathway Na-na Tang1,2, Chang-wen Wu1, Ming-qi Chen3, Xue-ai Zeng3, Xiu-feng Wang3, Yu Zhang3 and Jun-shan Huang1,3* 1Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, 350122, 2Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi, 330004, 3The Sleep Research Center of Fujian Provincial Institute of Traditional Chinese Medicine, Fuzhou, Fujian 350003, China. *For correspondence: Email: [email protected] Sent for review: 27 January 2017 Revised accepted: 5 August 2017 Abstract Purpose: To investigate the therapeutic effects of Jiaotai pill (JTP) on rats with insomnia induced by p- chlorophenylalanine (PCPA). Methods: Rats with PCPA-induced insomnia were divided into 5 groups (n = 10), made up of control group, positive treatment group (estazolam 0.1 mg/kg), and 3 JTP treatment groups (0.6, 1.2 and 2.4 g/kg). Another group of 10 rats were treated as normal group. Rats in normal and control groups were treated with normal saline (10 mL/kg). After 14 days of drug treatment, the rats were injected intraperitoneally with sodium pentobarbital (45 mg/kg) and thereafter, latent period and sleeping time were recorded, while contents of γ-aminobutyric acid (GABA) and glutamic acid (Glu) in hypothalamus were determined by high performance liquid chromatography (HPLC).
    [Show full text]
  • Control of Choline Oxidation in Rat Kidney Mitochondria
    ÔØ ÅÒÙ×Ö ÔØ Control of Choline Oxidation in Rat Kidney Mitochondria Niaobh O’Donoghue, Trevor Sweeney, Robin Donagh, Kieran Clarke, Richard K. Porter PII: S0005-2728(09)00144-3 DOI: doi:10.1016/j.bbabio.2009.04.014 Reference: BBABIO 46295 To appear in: BBA - Bioenergetics Received date: 11 March 2009 Revised date: 27 April 2009 Accepted date: 29 April 2009 Please cite this article as: Niaobh O’Donoghue, Trevor Sweeney, Robin Donagh, Kieran Clarke, Richard K. Porter, Control of Choline Oxidation in Rat Kidney Mitochondria, BBA - Bioenergetics (2009), doi:10.1016/j.bbabio.2009.04.014 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT Control of Choline Oxidation in Rat Kidney Mitochondria Niaobh O’Donoghue, Trevor Sweeney, Robin Donagh, Kieran Clarke and Richard K. Porter * School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2 Ireland. *Correspondence to: Richard K. Porter, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2 Ireland. Tel. +353-1-8961617; Fax +353-1-6772400; Email: [email protected] Key words: choline, betaine, mitochondria, osmolyte, kidney, transporter ACCEPTED MANUSCRIPT Abbreviations: EGTA, ethylenebis(oxethylenenitrilo)tetraacetic acid; FCCP, carbonyl cyanide p-trifluoromethoxyphenylhyrazone; HEPES, 4-(2- hydroxyethyl)-1-peiperazine-ethanesulfonic acid; MOPS, (3-[N}- morphilino)propane sulphonic acid; TPMP, methyltriphenylphosphonium 1 ACCEPTED MANUSCRIPT ABSTRACT Choline is a quaternary amino cationic organic alcohol that is oxidized to betaine in liver and kidney mitochondria.
    [Show full text]